KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,354,524 | -3.7% | 37,539 | -2.5% | 0.05% | +5.9% |
Q2 2023 | $4,520,017 | +121.0% | 38,501 | +50.7% | 0.05% | +112.5% |
Q1 2023 | $2,045,613 | -3.4% | 25,551 | -4.4% | 0.02% | -7.7% |
Q4 2022 | $2,117,392 | +15.2% | 26,728 | +1.4% | 0.03% | +4.0% |
Q3 2022 | $1,838,000 | -2.7% | 26,363 | -8.3% | 0.02% | +4.2% |
Q2 2022 | $1,889,000 | -2.0% | 28,764 | -0.7% | 0.02% | +14.3% |
Q1 2022 | $1,928,000 | -8.8% | 28,980 | -4.2% | 0.02% | 0.0% |
Q4 2021 | $2,115,000 | +32.8% | 30,237 | -0.9% | 0.02% | +31.2% |
Q3 2021 | $1,593,000 | -24.3% | 30,518 | -1.4% | 0.02% | -23.8% |
Q2 2021 | $2,105,000 | -15.4% | 30,956 | -4.1% | 0.02% | -19.2% |
Q1 2021 | $2,488,000 | +21.7% | 32,289 | -5.2% | 0.03% | +13.0% |
Q4 2020 | $2,044,000 | +63.4% | 34,075 | +17.2% | 0.02% | +35.3% |
Q3 2020 | $1,251,000 | +14.2% | 29,069 | +10.0% | 0.02% | +13.3% |
Q2 2020 | $1,095,000 | -10.2% | 26,431 | -6.3% | 0.02% | -25.0% |
Q1 2020 | $1,220,000 | -25.2% | 28,219 | -4.2% | 0.02% | -4.8% |
Q4 2019 | $1,631,000 | – | 29,460 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |